Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma
Po-Yi Chen,1,2 Chih-Kai Chang,3 Bang-Bin Chen,3 Chih-Hung Hsu,1,2,4 Ann-Lii Cheng,1,2,4 Yu-Yun Shao1,2,4 1Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; 2Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 3Department of Medical Ima...
Saved in:
| Main Authors: | Chen PY, Chang CK, Chen BB, Hsu CH, Cheng AL, Shao YY |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/treatment-outcomes-of-systemic-therapies-for-infiltrative-hepatocellul-peer-reviewed-fulltext-article-JHC |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
by: Atsushi Naganuma, et al.
Published: (2025-01-01) -
The double-edged sword: impact of antibiotic use on immunotherapy efficacy in advanced hepatocellular carcinoma
by: Yang Li, et al.
Published: (2025-04-01) -
Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01) -
Real-world efficacy of cabozantinib alone or in combination with ICIs in heavily pretreated hepatocellular carcinoma: potential role of AXL and MET expression
by: Kuan-Chang Lai, et al.
Published: (2025-07-01) -
Correlation Between Treatment‐Related Adverse Events and Efficacy of Camrelizumab in Combination With Apatinib in Patients With Unresectable Hepatocellular Carcinoma
by: Ting Zhang, et al.
Published: (2025-03-01)